Xingjun Ke
Research Subjects
Research Interests
Xingjun Ke has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Aishi Xu
1 shared publication- Daxin Pang
College of Animal Sciences, Jilin University, Changchun 130062, China
1 shared publication - Dongmei Lv
College of Animal Sciences, Jilin University, Changchun 130062, China
1 shared publication Fengyu Wu
1 shared publicationHongsheng Ouyang
1 shared publicationJiaqi Wang
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1)
Progress Toward Antigenic Epitopes of African Swine Fever Virus and Their Identification
African swine fever virus (ASFV) is a highly contagious pathogen that causes pigs to develop high fever, vomiting, diarrhea, and respiratory distress, with an exceptionally high case fatality rate. Unfortunately, vaccine development is hindered by a limited understanding of the structure and function of the protein encoded by ASFV, as well as the mechanisms underlying infection and immunity. Among these factors, the lack of effective cellular epitopes represents a major obstacle to vaccine development. Epitopes serve as the smallest structural units capable of inducing immune responses and are critical targets for both vaccine design and diagnostic reagent development. Therefore, it is imperative to investigate antigens with high immunogenicity and elucidate their correlation with protective immune responses to provide scientific insights and a theoretical foundation for developing safe and effective ASFV vaccines. Currently, thorough reviews on the identification and functional characterization of ASFV antigenic epitopes remain scarce. To address this gap, this paper provides a comprehensive review of ASFV epitopes and their identification strategies. It initiates with a systematic classification of ASFV antigenic epitopes, followed by an extensive discussion of various methods for identifying ASFV epitopes, along with their advantages and limitations. Furthermore, the paper summarizes existing databases of characterized ASFV antigenic epitopes and highlights the most biologically significant ones. In addition, the paper explores emerging applications of ASFV epitopes while addressing the technical challenges in epitope‐based research to provide valuable insights for ASFV vaccine development and production.
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1)
Open AccessProgress Toward Antigenic Epitopes of African Swine Fever Virus and Their Identification
African swine fever virus (ASFV) is a highly contagious pathogen that causes pigs to develop high fever, vomiting, diarrhea, and respiratory distress, with an exceptionally high case fatality rate. Unfortunately, vaccine development is hindered by a limited understanding of the structure and function of the protein encoded by ASFV, as well as the mechanisms underlying infection and immunity. Among these factors, the lack of effective cellular epitopes represents a major obstacle to vaccine development. Epitopes serve as the smallest structural units capable of inducing immune responses and are critical targets for both vaccine design and diagnostic reagent development. Therefore, it is imperative to investigate antigens with high immunogenicity and elucidate their correlation with protective immune responses to provide scientific insights and a theoretical foundation for developing safe and effective ASFV vaccines. Currently, thorough reviews on the identification and functional characterization of ASFV antigenic epitopes remain scarce. To address this gap, this paper provides a comprehensive review of ASFV epitopes and their identification strategies. It initiates with a systematic classification of ASFV antigenic epitopes, followed by an extensive discussion of various methods for identifying ASFV epitopes, along with their advantages and limitations. Furthermore, the paper summarizes existing databases of characterized ASFV antigenic epitopes and highlights the most biologically significant ones. In addition, the paper explores emerging applications of ASFV epitopes while addressing the technical challenges in epitope‐based research to provide valuable insights for ASFV vaccine development and production.